Doctors Health Press Reports on Study: New Class of Diabetes Medications Found to Double Risk of Pancreatitis

Doctors Health Press, a division of Lombardi Publishing Corporation, and publisher of various natural health newsletters, books, and reports, including the popular online Doctors Health Press e-Bulletin, is reporting on a new study finding that a brand new class of diabetes medications allegedly doubles a person’s risk of pancreatitis, leading to hospitalization.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
doctors health press

Doctors Health Press Reports on Study: New Class of Diabetes Medications Found to Double Risk of Pancreatitis

New Diabetes Drug Doubles Pancreatic Cancer Risk.

Boston, MA (PRWEB) March 17, 2013

Doctors Health Press, a division of Lombardi Publishing Corporation, and publisher of various natural health newsletters, books, and reports, including the popular online Doctors Health Press e-Bulletin, is reporting on a new study finding that a brand new class of diabetes medications allegedly doubles a person’s risk of pancreatitis, leading to hospitalization.

As Doctors Health Press e-Bulletin (http://www.doctorshealthpress.com/diabetes-articles/new-diabetes-drugs-double-pancreatitis-risk) notes, the new class of drugs the study is talking about, GLP-1, is used to control blood sugar levels. But, according to scientists, these drugs reportedly help form lesions in the pancreas and promote inflammation throughout the organ. Some brand names include “Januvia” and “Byetta.”

As the article “New Diabetes Drug Doubles Pancreatic Cancer Risk” reports, for years, the Food and Drug Administration (FDA) and doctors have known that pancreatitis might be a side effect of GLP-1 therapies. But this is the first evidence that accurately gauges the risk that stems specifically from the drug and not, for instance, from other things like obesity and heavy drinking.

The Doctors Health Press e-Bulletin article states that for millions of Americans, these drugs effectively lower blood glucose levels. But, sometimes with new drugs, it takes a while for certain side effects to materialize. So, the article warns that anyone taking these drugs should be aware of an increased risk to their pancreas, and should keep watch for symptoms such as stomach pain, nausea, and persistent vomiting.

As Doctors Health Press e-Bulletin reports, the new study is based on data from more than 1,200 people with type 2 diabetes who used at least one drug to treat the disease. Compared to people with diabetes who had not taken those drugs, the people on GLP-1 drugs were twice as likely to be hospitalized within two months.

The article explains that pancreatitis occurs when the organ suffers inflammation. It is both painful and dangerous if it goes untreated. For diabetics, the pancreas is already part of the problem, because either it doesn’t secrete enough insulin or the body is not able to respond to the hormone. With insulin issues, sugar can’t leave the blood to transport to other cells and it starts building up. A diabetic is already at higher risk of pancreatitis. This drug class then reportedly doubles that already-inflated risk.
(SOURCE: Singh, S., et al., “Glucagonlike Peptide 1-Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus,” JAMA Intern Med; published online February 25, 2013.)

Doctors Health Press e-Bulletin is a daily e-letter providing natural health news with a focus on natural healing through foods, herbs, and other breakthrough health alternative treatments. For more information on Doctors Health Press, visit http://www.doctorshealthpress.com.

Doctors Health Press believes in the healing properties of various alternative remedies, including Traditional Chinese Medicine. To see a video outlining the Doctors Health Press’ views on Traditional Chinese Medicine, visit http://www.doctorshealthpress.com/chinesemedicine.


Contact

Follow us on: Contact's Facebook Contact's Twitter

Past News Releases Group Rss Subscribe